Manulife (Manufacturers Life Insurance)
AMLX icon

Manulife (Manufacturers Life Insurance)’s Amylyx Pharmaceuticals AMLX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$679K Sell
37,828
-953
-2% -$14.7K ﹤0.01% 2125
2026
Q1 		$539K Buy
38,781
+11,793
+44% +$166K ﹤0.01% 2128
2025
Q4 		$326K Buy
26,988
+3,198
+13% +$43.4K ﹤0.01% 2335
2025
Q3 		$323K Sell
23,790
-2,209
-8% -$20.8K ﹤0.01% 2361
2025
Q2 		$167K Buy
+25,999
New +$126K ﹤0.01% 2625
2024
Q2 		– Sell
-95,570
Closed -$271K – 2965
2024
Q1 		$271K Buy
95,570
+9,922
+12% +$130K ﹤0.01% 2442
2023
Q4 		$1.26M Buy
85,648
+58,518
+216% +$897K ﹤0.01% 1689
2023
Q3 		$497K Buy
27,130
+6,299
+30% +$133K ﹤0.01% 2147
2023
Q2 		$449K Buy
20,831
+612
+3% +$16.5K ﹤0.01% 2111
2023
Q1 		$593K Buy
20,219
+83
+0.4% +$2.88K ﹤0.01% 1907
2022
Q4 		$744K Buy
+20,136
New +$715K ﹤0.01% 1755

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AMLX Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Amylyx Pharmaceuticals (AMLX) stake by 2.5% in Q2 2026, selling an estimated $14.7K and leaving 37,828 shares worth $679K. The position accounts for ﹤0.01% of the portfolio, ranked #2125.

Manulife (Manufacturers Life Insurance) first reported a position in AMLX in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.26M in Q4 2023. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 37,828 shares of Amylyx Pharmaceuticals worth $679K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 953 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $14.7K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2125 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Amylyx Pharmaceuticals in Q4 2022 and has held it in 11 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Amylyx Pharmaceuticals position peaked at $1.26M in Q4 2023.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.